Dr Lal Path Labs Shares Surge After Q1

Economic Times · business

Dr Lal Path Labs shares experienced a significant surge of 8% following a strong Q1FY27 earnings report that surpassed estimates. This growth was propelled by increased realisations and strategic price adjustments. Several brokerages, including Nomura and Nuvama, have raised their target prices, anticipating continued robust growth, network expansion, and improving profit margins in the diagnostics sector.